Register to receive a free US Market Report Suite for Diagnostic Ophthalmic Devices 2017 – MedSuite report synopsis and brochure
According to a new series of reports on the U.S. market for diagnostic ophthalmic devices by iData Research, manufacturers are introducing new technologies into fundus camera systems, including angiography and fluorescent dye tracking. As a result, total fundus camera unit sales are moderately growing. Table mounted sales for both imaging modalities are being driven by the replacement of older technology. The natural growth of the market associated with the increase in the elderly populations which is directly correlated with the incidence of ocular disease.
This market includes mydriatic and non-mydriatic fundus cameras. Each of the segments are further divided into table mounted and handheld devices. The persistent growth of the market is driven by the prevalence of age-related ocular conditions, such as glaucoma and macular degeneration. However, the average selling price for the total fundus camera market will depreciate over the next several years. This decrease can partially be attributed to the influx of inexpensive handheld devices and the competitive nature of the market that is being seen across all fundus camera segments. As a result, the significantly less expensive handheld mydriatic market is strongly outpacing the unit growth of the established table mounted market. Furthermore, the table mounted market is losing ground to combination devices which incorporate fundus cameras into other ophthalmic equipment.
“Traditionally the non-mydriatic fundus camera has been the choice of optometrists for several reasons; it is less expensive, the additional capabilities were not used as much by optometrists, and the need for chemical pupil dilation was an inconvenience for patients post procedure,” explains Jeffrey Wong, Strategic Analyst Manager at iData Research. “This is beginning to change as the increased range of capabilities offered by mydriatic cameras can also be a competitive advantage for an optometrist seeking patients.”
Topcon is the leading competitor in the U.S. fundus camera market. The company manufactures table mounted fundus cameras for both the mydriatic and non-mydriatic market. As part of the table mounted non-mydriatic fundus cameras Topcon manufactures the TRC-NW8®, TRC-NW8F® and the TRC-NW400®. In the mydriatic market Topcon manufactures the TRC-50DX® Series.
Carl Zeiss Meditec is the second leading competitor in the U.S. fundus camera market. The company manufactures five fundus cameras, and participates in all segments of this market. Their latest fundus camera, the VISUCAM® 224 has a 24-megapixel sensor for high resolution images. Additional competitors in the U.S. fundus camera market include Canon and Kowa among others.
For Further Information
More on the diagnostic ophthalmic market in the U.S can be found in a series of reports published by iData Research entitled the U.S. Market Report Suite for Diagnostic Ophthalmic Devices. The suite covers reports on the following markets: Ophthalmic coherence tomography, fundus cameras, data management systems, slit lamps, perimeters, tonometers, autorefractors/keratometers, binocular indirect ophthalmoscopes, ophthalmic ultrasound devices, wavefront abberometers, corneal topographers and optical biometers.
The iData report series on ophthalmic devices covers the U.S. and 15 countries in Europe including Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands and Luxemburg), Scandinavia (Finland, Denmark, Sweden and Norway), Portugal, Austria and Switzerland. Reports provide a comprehensive analysis including units sold, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. To find out more about ophthalmic device market data, register online or email us at [email protected] for a U.S. Market Report Suite for Diagnostic Ophthalmic Devices brochure and synopsis.